Horizon Therapeutics
(NASDAQ) HZNP
This security has been delisted. This page is retained for historical reference.
HZNP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowHZNP Financials
Key Financial Metrics (TTM)
Gross Margin
74.64%
Operating Margin
17.01%
Net Income Margin
14.37%
Return on Equity
10.70%
Return on Capital
8.09%
Return on Assets
5.72%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.74B
Operating Income
$513.37M
EBITDA
$958.10M
Operating Cash Flow
$1.04B
Capital Expenditure
-$134.52M
Free Cash Flow
$906.13M
Cash & ST Invst.
$2.46B
Total Debt
$2.56B
Horizon Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$944.96M
+7.8%
Gross Profit
$725.00M
+12.2%
Gross Margin
76.72%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
2,190
N/A
Net Income
$127.07M
+108.4%
EBITDA
$243.64M
+2.6%
Quarterly Fundamentals
Total Cash
$2.46B
+30.2%
Total Debt
$2.56B
-0.4%
Accounts Receivable
$717.42M
+6.6%
Inventory
$170.33M
-16.4%
Long Term Debt
$2.54B
-0.4%
Short Term Debt
$16.00M
+0.0%
Return on Assets
5.72%
N/A
Return on Invested Capital
7.56%
N/A
Free Cash Flow
$143.00M
-40.2%
Operating Cash Flow
$161.47M
-35.2%